Sign in
4

Changes in Ownership

Tyra Biosciences, Inc. Filed Acc 0000950170-24-030932

Chief Operating Officer sold 200 shares at $20.00 ($4,000)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Bensen Daniel Chief Operating Officer 2024-03-11 Sale 10b5-1 −200 $20.00 $4,000 431,683 D: show line 1 in the form
Open-market sales · 200 sh · avg $20.00 · $4,000
Loading xslF345X05/ownership.xml…